Clinical stage biotechnology company MiNK Therapeutics wrapped its initial public offering, selling 3.333 million shares at $12 each, the low end of its $12 to $14 range.

Shares of INKT will commence trading on the Nasdaq later today, but the stock is available for limit orders on Robinhood and other platforms.

Our top picks for where to buy MiNK Therapeutics stock

Top pick for stock bonuses

Go to site

Finder Reward

Get $150 from Finder

Become a Finder member, open a SoFi Active Invest account and make a first deposit of $1,000 or more to receive a $150 gift card. Offer ends November 30, 2025.
T&Cs and limits apply.

• Trade stocks, options, ETFs, mutual funds, alternative asset funds
• $0 commission on stocks, ETFs and options with no options contract fees
• Get up to $1,000 in stock when you open and fund a new account within 30 days
• Access to a financial planner

Disclaimer

Probability of Member receiving $1,000 is a probability of 0.026%; If you don’t make a selection in 45 days, you’ll no longer qualify for the promo. Customer must fund their account with a minimum of $50.00 to qualify. Probability percentage is subject to decrease.

Terms and conditions apply*. For 401k rollovers, existing SoFi IRA members must complete 401k rollovers via this link For SoFi members without a SoFi IRA, a SoFi IRA must first be opened, and 401k rollover must be completed utilizing Capitalize via this link. SoFi and Capitalize will charge no additional fees to process a 401(k) rollover to a SoFi IRA. SoFi is not liable for any costs incurred from the existing 401k provider for rollover. Please check with your 401k provider for any fees or costs associated with the rollover. For IRA contributions, only deposits made via ACH and cash transfer from SoFi Bank accounts are eligible for the match. Click here for the 1% Match terms and conditions.

Up to 2% match

Go to site

• Trade stocks, ETFs, options, futures and bonds all in one place
• $0 commissions on stocks, ETFs and equity options, with low contract fees
• Deposit or transfer $10,000+ to earn a 2% Match Bonus. Plus: Get a $100 transfer fee reimbursement on your first brokerage transfer of $2,000 or more. T&C apply.

Top pick for beginners

Go to site

• Trade stocks, options and ETFs without commissions and no options contract fees
• Earn 3.75% annual interest on options balances
• Copy top crypto investors with eToro's innovative CopyTrader
• Trade leading cryptocurrencies including BTC and ETH

Buy MiNK Therapeutics stock from these online trading platforms

{"userFilters":[{"config":{"MULTISELECT":true,"VALUES":"Brokerage,IRA,Education (529),Custodial,Other,Joint brokerage,Trust,Margin, Junior Roth IRA, Stock picking, Financial advisor,Kids investing,Alternative investing,Options,Market analysis,Self-directed IRA"},"dataSelector":{"recordType":"product","fieldCode":"DETAILS.ACCOUNT_TYPE"},"dataType":"TEXT","label":"Account type","order":null},{"config":{"MULTISELECT":true,"VALUES":"Stocks,Bonds,Options,Mutual funds,ETFs,Cryptocurrency,Real estate,Currencies,Gold\/Commodities,Art,CDs,Futures,Forex,Other,Alternatives,Savings,Investments,Retirement,Treasury Bills,Wine,Whiskey, Event contracts,Collectibles,Private credit, Venture capital,Annuities,Insurance, High-yield cash account, N\/A, Precious metals, Investment funds, Private equity, Tax liens\/deeds, Money market funds, Financial advisor marketplace"},"dataSelector":{"recordType":"product","fieldCode":"DETAILS.ASSET_TYPES"},"dataType":"TEXT","label":"Asset types","order":null},{"config":{"MULTISELECT":true,"VALUES":"Roth, Traditional, SEP, Spousal, Rollover, Beneficiary Traditional, Beneficiary Roth, Gold Traditional IRA, Gold Roth IRA, Custodial, SIMPLE, Self-directed, Inherited, Junior Roth IRA, Self-Directed IRA, Checkbook IRA, Solo 401(k), SEP IRA"},"dataSelector":{"recordType":"product","fieldCode":"DETAILS.IRA_ACCOUNT_TYPE"},"dataType":"TEXT","label":"Retirement account types","order":null},{"config":{},"dataSelector":{"recordType":"product","fieldCode":"FEES.FEE_TRADE_STOCK"},"dataType":"MONEY","label":"Stock trade fee","order":null},{"config":{},"dataSelector":{"recordType":"product","fieldCode":"REQUIREMENTS.MIN_DEPOSIT"},"dataType":"MONEY","label":"Minimum deposit to open","order":null},{"config":{},"dataSelector":{"recordType":"product","fieldCode":"REQUIREMENTS.MIN_TREASURY_BILLS_DEPOSIT"},"dataType":"MONEY","label":"Minimum Treasury Bills investment","order":null}],"niche":{"currencySymbol":"$","decimalPoint":".","decimalPlaces":"2","thousandsSeparator":",","filterBoundsMap":{"product.DETAILS.ACCOUNT_TYPE":null,"product.DETAILS.ASSET_TYPES":null,"product.DETAILS.IRA_ACCOUNT_TYPE":null,"product.FEES.FEE_TRADE_STOCK":{"minimum":"0","maximum":"4.95"},"product.REQUIREMENTS.MIN_DEPOSIT":{"minimum":"0","maximum":"1000000"},"product.REQUIREMENTS.MIN_TREASURY_BILLS_DEPOSIT":{"minimum":"100","maximum":"1000"}}},"prefilled":false,"experimental":false}

12 of 12 results

Finder Score	Available asset types	Stock trade fee	Minimum deposit	Cash sweep APY	bullet point infobox
Finder Rewards ExclusivePromoted Finder score 9 Excellent SoFi Active Invest	Finder score 9 Excellent	Stocks, Options, Mutual funds, ETFs, Alternatives	$0	$0	0.01%	ENDS SOON! $150 VISA CARD SIGNUP BONUS 1 Join Finder 2 Sign up to SoFi and make a $1,000 deposit 3 Get a digital Visa gift card from Finder Ends by. T&Cs and limits apply.	Get up to $1,000 in stock when you open and fund a new account. T&Cs apply.	Trade stocks, ETFs, and options with zero commissions, invest in IPOs or automate your portfolio, with exclusive perks available through SoFi Plus.	Go to site More info	loading
Promoted Finder score 9 Excellent Wealthfront	Finder score 9 Excellent	Stocks, ETFs, High-yield cash account	$0	$500	3.75%	Get a $50 bonus when you sign up and fund a taxable automated investing account with at least $500. T&Cs apply.	Automate your stock and bond portfolio or trade individual stocks for as little as $1 apiece. Plus, earn 3.75% APY on your cash.	Go to site More info	loading
Promoted Finder score 9.4 Excellent Robinhood	Finder score 9.4 Excellent	Stocks, Options, ETFs, Cryptocurrency, Futures, Event contracts, High-yield cash account	$0	$0	3.75%	Get a free stock when you successfully sign up and link your bank account. T&Cs apply.	Trade stocks, options, crypto and more, with advanced trading tools, fractional shares and exclusive perks for Gold members.	Go to site More info	loading
Finder score 9.4 Excellent Webull	Finder score 9.4 Excellent	Stocks, Bonds, Options, ETFs, Futures, Money market funds	$0	$0	3.85%	Deposit or transfer $100,000+ to earn a 4% Match Bonus, or $2,000+ to earn a 3% Match Bonus. Plus: Get a $100 transfer fee reimbursement on your first brokerage transfer of $2,000 or more. T&Cs apply.	Trade stocks, ETFs and equity options commission-free, with access to futures, advanced charting tools, a robo-advisor and event trading powered by Kalshi.	Go to site More info	loading
Finder score 8.2 Great eToro	Finder score 8.2 Great	Stocks, Options, ETFs, Cryptocurrency, Investments	$0	$0	3.75%	No commission stock, ETF and options trades, with 3.9% interest on your options account balance and no options contract fees. See full disclosure.	Go to site More info	loading
Finder score 9.2 Excellent Interactive Brokers GlobalTrader	Finder score 9.2 Excellent	Stocks, Options, Mutual funds, ETFs, Cryptocurrency	$0	$0	3.83% Lite 4.83% Pro	Trade in a simulated trading environment and access a wide range of tradable assets.	Go to site More info	loading
Finder score 8.2 Great Zacks Trade	Finder score 8.2 Great	Stocks, Bonds, Options, Mutual funds, ETFs, CDs	$0.01	$250	2.83%	Leverage powerful trading tools and low margin rates to trade stocks, options, ETFs, mutual funds and bonds.	Go to site More info	loading
Finder score 9 Excellent Public.com	Finder score 9 Excellent	Stocks, Bonds, Options, ETFs, Cryptocurrency, Investments, Retirement, Treasury Bills, High-yield cash account	$0	$0	3.8%	Get up to $10,000 and transfer fees covered when you move your portfolio to Public. T&Cs apply.	Build a diversified portfolio of stocks, bonds, options, ETFs and crypto, with a high-yield cash account and options contract rebates.	Go to site More info	loading
Finder score 8 Great Acorns	Finder score 8 Great	Stocks, ETFs	$0	$0	N/A	Get a $20 bonus when you set up an account and make your first recurring investment (min. $5). T&Cs apply.	Automate investing with recurring contributions starting at $5 and invest spare change from everyday purchases.	Go to site More info	loading
Finder score 7.4 Great Stash	Finder score 7.4 Great	Stocks, ETFs	$0	$0	0.1%	Get $5 when you sign up and deposit $5. T&Cs apply.	Bank, automate your portfolio or invest in individual stocks and ETFs for as low as $3 per month.	Go to site More info	loading
Finder score 7.2 Great J.P. Morgan Personal Advisors	Finder score 7.2 Great	Mutual funds, ETFs	$0	$25,000	N/A	Financial planning, advice and portfolio management. T&Cs apply.	Get ongoing access to an advisory team with personalized financial planning and expert-built portfolios. Provider terms & conditions apply	More info	loading
Finder score 8.2 Great M1 Finance	Finder score 8.2 Great	Stocks, ETFs, Cryptocurrency	$0	$100	4.00%	Build a custom portfolio of stocks and ETFs with automatic rebalancing. Plus, earn 4.00% APY with a high-yield cash account.	More info	loading

loading

Load More

Showing 12 of 12 results

What is the Finder Score?

The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.

We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.

Read the full Finder Score breakdown

MiNK Therapeutics stock price (NASDAQ: INKT)

Is it a good time to buy MiNK Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

MiNK Therapeutics share dividends

We're not expecting MiNK Therapeutics to pay a dividend over the next 12 months.

You may also wish to consider:

• Pfizer (PFE.US) (6.9% forward annual dividend yield)

Have MiNK Therapeutics's shares ever split?

MiNK Therapeutics's shares were split on a 1:10 basis on 27 January 2025 . So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your MiNK Therapeutics shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for MiNK Therapeutics shares which in turn could have impacted MiNK Therapeutics's share price.

MiNK Therapeutics share price volatility

Over the last 12 months, MiNK Therapeutics's shares have ranged in value from as little as $4.5601 up to $76. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while MiNK Therapeutics's is 0.332. This would suggest that MiNK Therapeutics's shares are less volatile than average (for this exchange).

To put MiNK Therapeutics's beta into context you can compare it against those of similar companies.

• Pfizer (PFE.US): 0.465
• Sanofi ADR (SNY.US): 0.442
• Biogen (BIIB.US): 0.125

MiNK Therapeutics overview

MiNK Therapeutics, Inc. , a clinical-stage biopharmaceutical company, engages in the discovery, development, manufacture, and commercialization of allogeneic, off-the-shelf, and invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company develops agenT-797, an off-the-shelf, allogeneic, and native iNKT cell therapy that is in Phase 2 clinical trial for the clinical safety and efficacy of the combination of agenT-797, botensilimab plus balstilimab with ramucirumab and paclitaxel for patients with previously treated, advanced esophageal, gastric, or gastro-esophageal junction adenocarcinoma; Phase 1 trial as a monotherapy in combination with anti-PD-1 checkpoint inhibitors, pembrolizumab, and nivolumab for refractory solid tumor cancers; and Phase 1 trial for the treatment of moderate to severe viral acute respiratory distress syndrome. It is also developing MiNK-215, an IL-15 armored tumor stromal targeting the FAP-CAR-iNKT program to treat solid tumors and inflammation; and MiNK-413, an IL-15 armored CAR-iNKT program targeting B cell maturation antigen for auto-immune diseases. The company has collaborations with Autonomous Therapeutics to target and treat metastatic tumors; and ImmunoScape, Inc. to discover and develop T-cell receptor therapies against targets in solid tumors. The company was formerly known as AgenTus Therapeutics, Inc.

Frequently asked questions